George L. Sing - 26 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
26 Feb 2024
Net transactions value
-$579,170
Form type
4
Filing time
28 Feb 2024, 16:04:19 UTC
Previous filing
26 Feb 2024
Next filing
06 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $206,665 +500 +1.9% $413.33 26,849 26 Feb 2024 Direct
transaction REGN Common Stock Sale $495,000 -500 -1.9% $990.00 26,349 26 Feb 2024 Direct
transaction REGN Common Stock Options Exercise $206,665 +500 +1.9% $413.33 26,849 26 Feb 2024 Direct
transaction REGN Common Stock Sale $497,500 -500 -1.9% $995.00 26,349 26 Feb 2024 Direct
holding REGN Common Stock 750 26 Feb 2024 by Spouse
holding REGN Common Stock 400 26 Feb 2024 by Spouse/Cust Son
holding REGN Common Stock 1,000 26 Feb 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -16% $0.000000 5,338 26 Feb 2024 Common Stock 1,000 $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.